Member Info for doze

SFAR in France, NICE in USA, top advice to trusts in UK. Traction achieved.

I have special dispensation for doziness

sorry

wouldn't let me copy and paste- several attempts seem to have accumulated.

8                  -  !      ^$  =     &!8         $     w      &!#  $ 8             $      !#          8                  -  !      ^$  =     &!8         $     w      &!#  $ 8             $      !#          http://www.provenvcts.co.uk/pdf/2012-ProVen-Health-Annual-Report-and-Accounts-31-01-12.pdf very similar to xen I think  

That is 2x the market cap of xen, just shows our investment needs large pharma/in the know tycoons to join in and we are dependant on their speed to market not anything we/xen can do.

http://www.investegate.co.uk/eservglobal-limited/esg/homesend-announces-new-corridor-with-postfinance/201305010700166628D/?fe=1&utm_source=FE%20Investegate%20Alerts&utm_medium=Email&utm_content=Announcement%20Alert%20Mail&utm_campaign=eServGlobal%20Limited%20Alert

eServGlobal currently provides airtime recharge solutions to several of the group operations, and this contract underlines the strategic importance of the Company's existing PayMobile footprint. Can someone tell me what an airtime recharge solution is in this context?

The fantastical prose reaching ever greater heights may be piling too much pressure on the XEN hierachy. I was at Master Investor and one pundit said the individual gene sequencing slot that personalizes treatment by identifying needs and the companies that support the dissemination of this info was the hot area at the moment. Another one said zombie pharmas can sometimes take off after years of doing nothing. One company he mentioned took over another and transformed itself, up 2000% I think he said.

http://newsroom.tissueregenix.com/approval-given-for-start-of-clinical-research-trial-to-examine-the-effectiveness-of-tissue-regenixs-dcell-dermis-matrix-in-treat/

Corporate rating confirmed probably means xen can be bought OTC in US ie xen are listed in US on the market equivalent of aim over there so may boost sales of xen shares. I would have thought an rns would have been issued this am about this unless it is not a significant event which may be it is not.

An overdue rerating perhaps. Always fancied this but sold out recently to cover a trade, thus switching holdings. Shame. Has happened on many of my second tier holdings which I shpould have given top ratings.

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11396465

Expenses are extremely favourable, churn rate extremely low therefore confidence in future profit extremely high when coffers will be filled again. CEO/family receives huge div payout.

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11350223

Good call http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11348984 Just sold my stake nice 40% profit.

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11337159

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11336629

7/9/12 I think, price 62 at open 72.37 at close.

A longterm holding, that was March 2009 tip